In simple terms, Mounjaro provides all the insulin release, appetite regulation and blood sugar control benefits of a GLP-1 medication, but its additional targeting of GIP receptors enhances these effects
Online, some wonder what's different now, months after the shortage was declared over
Those who switched to the pill from injectable Wegovy regained an average difference of 2 pounds, while those who switched to Foundayo from Zepbound gained an average of 11 pounds
Optimal needling protocols Needle depth affects results significantly
The average weight loss on retatrutide in clinical trials has been up to 24% of body weight, which is significantly higher than other GLP-1 receptor agonists like semaglutide
Getting your 510(k) clearance is great, but youll need clinical evidence if you want clinicians to begin choosing your device over its predicate